Artigos

Search for articles

BJO Oncology - Placeholder

PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil

Cronemberger, Eduardo ID
,
Assad, Daniele Xavier ID
,
Cossetti, Rachel ID
,
de-Azevedo, Carla Rameri ID
,
Calabrich, Aknar FC ID
,
Morelle, Alessandra Menezes ID
,
Melo, Andreia C ID
,
Nunes, João Soares ID
,
Nogueira-Rodrigues, Angelica ID
,
Maluf, Fernando C ID
,
Guindalini, Rodrigo ID
,
Crosara, Marcela ID
,
Dal-Molin, Graziela ID
,
Leite, Ana Carolina ID
,
Kalil, Karime ID
,
Paulino, Eduardo ID
,
Signorini, Poliana ID
,
de-Freitas, Daniela ID
,
Almeida, Michelle Samora ID
,
Guimarães, Andrea PG ID
ABSTRACT To report consensus recommendations on the current role of poly(ADP-ribose) polymerase (PARP) inhibitors in the front-line management of patients with epithelial ovarian cancer (EOC) in the healthcare setting of Brazil. The expert panel convened in March 2021 and comprised 20 medical oncologists focus on gynecological oncology. The panel answered...
Read abstract
Complete article
Download article